|
2022
|
Invention
|
Chimeric antigen receptors against multiple hla-g isoforms. The present invention relates to chim... |
|
|
Invention
|
Anti hla-g specific antibodies. The present invention relates to antibodies, or antigen-binding f... |
|
2021
|
Invention
|
Chimeric constructs useful in vaccination and cancer therapy. The present invention provides nucl... |
|
|
Invention
|
Polyepitope constructs for use in immunotherapy.
The present invention relates to DNA expression... |
|
|
Invention
|
Anti hla-g specific antibodies.
The present invention relates to antibodies, or antigen-binding ... |
|
2020
|
Invention
|
Single-domain antibodies directed against lilrb2. The present invention relates to single-domain ... |
|
2019
|
Invention
|
Method to assess car functionality.
The present invention relates a method for assessing the fun... |
|
|
Invention
|
Method to assess car functionality. The present invention relates a method for assessing the func... |
|
2018
|
Invention
|
Cancer vaccine for dogs.
The present invention provides an immunogenic composition comprising a ... |
|
|
Invention
|
Telomerase encoding dna vaccine. The invention provides a nucleic acid construct comprising a seq... |
|
|
Invention
|
Recombinant measles vaccine expressing htert. The invention relates a recombinant measles virus p... |
|
|
Invention
|
Cancer vaccine for cats. The present invention provides a nucleic acid, or an immunogenic composi... |
|
2017
|
Invention
|
Universal cancer peptides derived from telomerase. The invention relates to a peptide of 15 to 20... |
|
2016
|
Invention
|
Polyepitope constructs for use in immunotherapy. The present invention relates to DNA expression ... |
|
|
Invention
|
Polyepitope constructs for use in immunotherapy. The present invention relates to DNA ... |
|
2014
|
Invention
|
Gene electrotransfer into skin cells. The present invention relates to methods for transferring a... |
|
|
Invention
|
A telomerase encoding dna vaccine. The invention provides a nucleic acid construct comprising a s... |
|
|
Invention
|
Method of treating fibrosarcoma using a nucleic acid sequence encoding apobec3a. The present inve... |
|
|
Invention
|
Apobec3a as an anti-tumor agent. The present invention relates to the use of a nucleic acid that ... |
|
|
Invention
|
Cancer vaccine for dogs. The present invention provides an immunogenic composition comprising a n... |
|
|
Invention
|
A cancer vaccine for cats. The present invention provides an immunogenic composition comprising a... |
|
|
Invention
|
A cancer vaccine for dogs. The present invention provides an immunogenic composition comprising a... |
|
2013
|
Invention
|
Antibodies and fragments thereof raised against the alpha-3 domain of hla-g protein, methods and ... |